Overview

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients

Status:
Completed

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to learn more about the safety and tolerability of etravirine. Etravirine is a type of non-nucleoside reverse transcriptase inhibitor (NNRTI) which has shown high activity against wild-type human immunodeficiency virus (HIV-1), and HIV strains resistant to other non-nucleotide agents.

Phase:

Phase 4

Details

Lead Sponsor:

Janssen R&D Ireland

Treatments:

Anti-Retroviral Agents
Etravirine